Category: Multiple Sclerosis (MS)
Global Multiple Sclerosis (MS)
-
Multiple Sclerosis Drugs Global Market Report 2025
... market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective ... Read More
-
Beta Interferon
... CAGR of 3.0% over the analysis period 2024-2030. The U.S. Market is Estimated at US$968.9 Million While China is Forecast to Grow at 4.5% CAGR The Beta Interferon market in the U.S. is estimated at ... Read More
-
Multiple Sclerosis Drugs
... at a CAGR of 6.7% over the analysis period 2024-2030. Immmunomoderator Drugs, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$13.2 Billion by the end of ... Read More
-
Autoinjectors Market by Usage (Disposable, Reusable), Technology (Manual, Automatic), Therapy (Rheumatoid Arthritis, Diabetes, Obesity, Anaphypaxis, Multiple Sclerosis), Route of Administration (SC, IM), Volume (<3ml, >3ml) - Global Forecast to 2030
... is projected to surge to a value of USD 134.27 billion in 2030 from USD 67.30 billion in 2024, growing at a CAGR of 12.2%. Favorable reimbursement policies in North America and Europe coupled with ... Read More
-
Anti-inflammatory Drugs Market Size, Share, and Analysis, By Drug Type (Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Immune Selective Anti-inflammatory Derivatives, Anti-inflammatory Biologics, and Corticosteroids), By Application (Arthritis, Chronic Obstructive Pulmonary Disease, Multiple Sclerosis, Inflammatory Bowel Disease (IBD), and Others), By Route of Administration (Oral, Topical, Injection, and Inhalation), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034
... and Others), By Route of Administration (Oral, Topical, Injection, and Inhalation), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast ... Read More
-
Global Active Wheelchair Market Size, Share & Trends Analysis by Type (Manual Wheelchair, Powered Wheelchair), by Indication (Cerebral Palsy, Alzheimer’s Disease, Multiple Sclerosis), and Regional Forecasts 2022–2032
... witness significant growth, with the market size estimated at USD 1.58 billion in 2023 and projected to expand at a CAGR of 5.8% during the forecast period from 2024 to 2032. These mobility aids are ... Read More
-
PEGylated Proteins Market Report by Product (Consumables, Services), Protein Type (Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VII, and Others), Application (Cancer Treatment, Hepatitis, Chronic Kidney Diseases, Hemophilia, Multiple Sclerosis, Gastrointestinal Disorders, and Others), End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutes), and Region 2025-2033
... End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutes), and Region 2025-2033 The global PEGylated proteins market size reached USD 1.4 Billion in 2024. Looking forward, IMARC Group expects the market ... Read More
-
Global Stem Cell Therapy for Multiple Sclerosis Market Growth (Status and Outlook) 2024-2030
... million in 2023. With growing demand in downstream market, the Stem Cell Therapy for Multiple Sclerosis is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. ... Read More
-
Global Multiple Sclerosis Treatment Market Growth (Status and Outlook) 2024-2030
... demand in downstream market, the Multiple Sclerosis Treatment is forecast to a readjusted size of US$ 19060 million by 2030 with a CAGR of 2.1% during review period. The research report highlights the growth potential ... Read More
-
Global Stem Cell Therapy for Multiple Sclerosis Market 2024 by Company, Regions, Type and Application, Forecast to 2030
... size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. Multiple sclerosis is a nervous system disease, ... Read More
-
Global Targeted Drugs for Multiple Sclerosis Market Growth (Status and Outlook) 2024-2030
... it is expected to grow at a CAGR of %from 2024 to 2030. LPI (LP Information)' newest research report, the “Targeted Drugs for Multiple Sclerosis Industry Forecast” looks at past sales and reviews total world ... Read More
-
Stem Cell Therapy for Multiple Sclerosis Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type
... Sclerosis from 2019 to 2023 and its CAGR from 2019 to 2023, and also forecasts its market size to the end of 2029 and its CAGR from 2024 to 2029. For geography segment, regional supply, ... Read More
-
Global Multiple Sclerosis Drugs Treatment Market Growth (Status and Outlook) 2024-2030
... growing demand in downstream market, the Multiple Sclerosis Drugs Treatment is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth ... Read More
-
Global Multiple Sclerosis Therapeutics Market Growth (Status and Outlook) 2024-2030
... demand in downstream market, the Multiple Sclerosis Therapeutics is forecast to a readjusted size of US$ 19240 million by 2030 with a CAGR of 2.1% during review period. The research report highlights the growth potential ... Read More
-
Global Secondary Progressive Multiple Sclerosis Drug Market Growth 2024-2030
... demand in downstream market, the Secondary Progressive Multiple Sclerosis Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth ... Read More
-
Global Primary Progressive Multiple Sclerosis Treatment Market Growth (Status and Outlook) 2024-2030
... 2023. With growing demand in downstream market, the Primary Progressive Multiple Sclerosis Treatment is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report ... Read More
-
Global Progressive Relapsing Multiple Sclerosis Treatment Market Growth (Status and Outlook) 2024-2030
... 2023. With growing demand in downstream market, the Progressive Relapsing Multiple Sclerosis Treatment is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report ... Read More
-
Neurological Biomarkers Market Report by Type (Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers, and Others), Application (Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Autism Spectrum Disorders, and Others), End Use (Hospital Laboratories, Clinical Diagnostic Centers, Research Organizations, and Others), and Region 2024-2032
... Research Organizations, and Others), and Region 2024-2032 The global neurological biomarkers market size reached US$ 8.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 24.0 Billion by 2032, exhibiting a ... Read More
-
Multiple Sclerosis Therapies Market Report by Drug (Immunomodulators, Immunosuppressants), Drug Type (Biologic Drugs, Small Molecule Drugs), Route of Administration (Oral, Injectable, Intravenous), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2024-2032
... multiple sclerosis therapies market size reached US$ 26.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 37.8 Billion by 2032, exhibiting a growth rate (CAGR) of 3.7% during 2024-2032. Multiple ... Read More
-
Electronic Drug Delivery Systems Market by Type (Electronic Wearable Infusion Pump, Autoinjectors, Injection Pens, Electronic Inhalers), Indication (Diabetes, Multiple Sclerosis, Cardiovascular Disease, Asthma & COPD), Regional Outlook– Global Forecast up to 2030
... most thorough and iterative research technique available, with a primary focus on offering the most precise market projections and research data content to help you develop previously unheard-of levels of business acumen. The company's primary ... Read More
-
Global Multiple Sclerosis Treatment Market Report and Forecast 2024-2032
... grow at a CAGR of 4.10 % during the forecast period of 2024-2032, driven by advances in understanding individual genetic markers. The market is experiencing robust growth and is expected to reach USD 30.6 billion ... Read More
-
Global Specialty Pharmaceuticals Market 2024-2028
... report on the specialty pharmaceuticals market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding ... Read More
-
Global Multiple Sclerosis Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
... million in 2023 and is forecast to a readjusted size of USD 20850 million by 2030 with a CAGR of 4.8% during review period. Multiple sclerosis (MS) is a demyelinating disease in which the insulating ... Read More
-
2024 Global: Multiple Sclerosis Therapeutics Market - Innovative Markets Forecast (2030) report
... the period 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 ... Read More
-
Global Multiple Sclerosis (MS) Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
... USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. The global pharmaceutical market is 1475 billion USD in 2022, growing ... Read More
Research Assistance
